Biolight Life Sciences Ltd BLLSF의 지난 분기 매출 실적은 어땠나요?
Biolight Life Sciences Ltd의 매출 추정치는 얼마인가요?
Biolight Life Sciences Ltd의 수익 품질 점수는 얼마인가요?
Biolight Life Sciences Ltd는 언제 수익을 보고하나요?
Biolight Life Sciences Ltd의 예상 수익은 얼마인가요?
Biolight Life Sciences Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
BLLSF란 무엇인가요?
BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.